Skip to search formSkip to main contentSkip to account menu

SK&F 106615

Known as: SK&F-106615, Azaspirane SK&F106615, SK&F106615 
National Institutes of Health

Related topics

Related topics

2 relations
antiprimod

Broader (1)

azaspirane

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2017
Review
2017
A new approach for treatment of type 1 diabetes: Phytotherapy and phytopharmacology of regulatory T cells
Type 1 diabetes (T1D), which resulting in hyperglycemia, is an autoimmune disease. This disease characterized by destruction of… 
1999
1999
Selective inhibition of phospholipases by atiprimod, a macrophage targeting antiarthritic compound.
Azaspiranes are cationic amphiphilic compounds that are active in a number of models of autoimmune disease and transplantation… 
1998
1998
Evaluation of the cutaneous anti-inflammatory activity of azaspiranes
Abstract.Objective and Design: The ability of azaspiranes to modulate the acute inflammatory response in models of skin… 
1997
1997
Selective immunomodulatory activity of SK&F 106615, a macrophage-targeting antiarthritic compound, on antibody and cellular responses in rats and mice.
1993
1993
The azaspirane SKF 105685 ameliorates renal allograft rejection in rats.
The azaspirane SKF 105685 (N,N-dimethyl-8, 8-dipropyl-2-azaspiro (4.5) decane-2-propanamine dihydrochloride) has been shown to… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)